Dr. Sean E. Mazloom, MD

Dr. Mazloom practices at Dermatology Associates in Venice, Florida.

Dr. Mazloom's NPI, 1518256932, was assigned on April 6, 2011. Dr. Mazloom graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2011. Dr. Mazloom holds Florida license ME145595.

Dr. Mazloom's primary practice is Dermatology Associates, at 2389 E Venice Ave, Venice, FL 34292 in Sarasota County. The practice phone is (941) 529-0070.

Dr. Mazloom's primary practice is Dermatology Associates in Venice, Florida. Dr. Mazloom is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is REJUVA Dermatology. Dmand AI also links Dr. Mazloom to 1 more group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazloom practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Mazloom's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dr. Mazloom is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Mazloom's licenses on file in 7 states: Florida, New Jersey, New York, Texas, California, Virginia and Ohio.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, facial skin infection and itchy rashes among the conditions Dr. Mazloom treats.

CMS data shows 66,122 Medicare services from Dr. Mazloom across 43 procedure codes in 2024, for 755 Medicare patients. Medicare paid $1,992,508 for them. Every service was in an office.

CMS counts 755 Medicare patients who saw Dr. Mazloom in 2024. The largest group is 65 to 74, with 387 patients. 75% of them have high cholesterol, and 68% have high blood pressure. 2% are also on Medicaid. Their average risk score is 0.99, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Mazloom's median patient age at 74, with 49% women.

In 2024, Dr. Mazloom wrote 1,418 Medicare Part D claims for 614 patients. 99% of them were for generic drugs. CMS names the drug for 1,270 of them, across 15 drugs with 11 or more claims each, at $21,458 in total drug cost. In 2023, CMS named 713 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Mazloom for performance year 2024, reported as part of a group. Dr. Mazloom accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 5,306 procedures of removal of skin lesions by Dr. Mazloom, more than 99% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 1 paper to Dr. Mazloom. Dr. Mazloom's most frequent co-authors are Rahul N. Chavan, MD, Garrett Curtis Coman, MD and Mariana A. Phillips, MD.

CMS Open Payments shows 117 general payments to Dr. Mazloom from 35 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Organogenesis Inc. paid the most, $425.

Dr. Mazloom graduated from Chicago Medical School at Rosalind Franklin University of Medicine and Science in 2011.

Dr. Mazloom is in network with 17 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.